Related references
Note: Only part of the references are listed.Clinical Evaluation of Factor XIa Inhibitor Drugs JACC Review Topic of the Week
Josephine Harrington et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)
Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis
Mattia Galli et al.
THROMBOSIS AND HAEMOSTASIS (2023)
Predictive value for increased activated factor XI activity in acute venous thromboembolism
Magdolna Nagy et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2023)
Risk Factors for Post-Thrombotic Syndrome in Patients With a First Proximal Deep Venous Thrombosis Treated With Direct Oral Anticoagulants
Luca Spiezia et al.
ANGIOLOGY (2022)
Active FXI Can Independently Predict Ischemic Stroke in Anticoagulated Atrial Fibrillation Patients: A Cohort Study
Michal Tomasz Zabczyk et al.
THROMBOSIS AND HAEMOSTASIS (2022)
Clinical Pharmacology of Factor XI Inhibitors: New Therapeutic Approaches for Prevention of Venous and Arterial Thrombotic Disorders
Elena Campello et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Factor XI Deficiency
Magdalena Dorota Lewandowska et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)
Venous thromboembolism risk associated with ABO, F11 and FGG loci
Licinio Manco et al.
BLOOD COAGULATION & FIBRINOLYSIS (2018)
An update on factor XI structure and function
Bassem M. Mohammed et al.
THROMBOSIS RESEARCH (2018)
Associations between polymorphisms in coagulation-related genes and venous thromboembolism: A meta-analysis with trial sequential analysis (vol 96, e6537, 2017)
J. Jiang et al.
MEDICINE (2017)
New Prothrombin Mutation (Arg596Trp, Prothrombin Padua 2) Associated With Venous Thromboembolism
Cristiana Bulato et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
F11 is associated with recurrent VTE in women A prospective cohort study
Maria Bruzelius et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S
Elena Campello et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Prospective study of circulating factor XI and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE)
Aaron R. Folsom et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor
Cristina Puy et al.
BLOOD (2015)
Factor XI and contact activation as targets for antithrombotic therapy
D. Gailani et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
The dimeric structure of factor XI and zymogen activation
Yipeng Geng et al.
BLOOD (2013)
The diagnosis and treatment of venous thromboembolism
Philip Wells et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2013)
Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk
Hong Zhang et al.
BLOOD (2010)
Novel Hemostatic Factor Levels and Risk of Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study
M. Fareed K. Suri et al.
CEREBROVASCULAR DISEASES (2010)
Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology
Mary Cushman et al.
BLOOD (2009)
Factor XI contributes to thrombin generation in the absence of factor XII
Dmitri V. Kravtsov et al.
BLOOD (2009)
Genetic variants associated with deep vein thrombosis: the F11 locus
Y. Li et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and YII
Carine J. M. Doggen et al.
BLOOD (2006)
Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events
David T. Yang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Elevated levels of Factor XI are associated with cardiovascular disease in women
JI Berliner et al.
THROMBOSIS RESEARCH (2002)
Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease
C Merlo et al.
ATHEROSCLEROSIS (2002)
High levels of coagulation factor XI as a risk factor for venous thrombosis.
JCM Meijers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
